The effects of reactive species on the tumorigenic phenotype of human head and neck squamous cell carcinoma (HNSCC) cells

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 3819-3827

  Bradburn, Jennifer E ^a,b   Pei, Ping ^b   Kresty, Laura A ^a,c   Lang, James C ^a,c   Yates, Allan J ^a,c   McCormick, Adam P ^b   Mallery, Susan R ^a,b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

COX 2; Head and neck cancer; Inflammation; iNOS; Reactive species

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ARTICLE; CANCER RISK; CARCINOGENESIS; CARCINOMA CELL; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PARAMETER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; HEAD AND NECK NEOPLASMS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-8; NF-KAPPA B; OXIDATION-REDUCTION; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 37549053228     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007.
2. de Visser KE and Coussens LM: The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immunother 54: 1143-1152, 2005.
3. Grisham MB, Jourd'Heuil D and Wink DA: Nitric Oxide I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 276: G315-G321, 1999.
4. Joshi MS, Ponthier JL and Lancaster JR: Cellular Antioxidant and Pro-Oxidant Actions of Nitric Oxide. Free Rad Biol Med 27: 1357-1366, 1999.
5. Edwards J, Mukherjee R, Munro AF Wells AC, Almushatat A and Bartlett JM: HER2 and COX2 expression in human prostate cancer. Eur J Cancer 40: 50-55, 2004.
6. Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS and Kim KH: Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res 22: 2089-2096, 2002.
7. Li N, Sood S,Wang S, Fang M, Wang P, Sun Z, Yang CS and Chen X: Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib. Clin Cancer Res 11: 2089-2096, 2005.
8. Park JW, Park JE, Lee JA, Lee CW and Kim CM: Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells. J. Cancer Res Clin Oncol 132: 184-192, 2006.
9. Payne C M, Bernstein C, Bernstein H, Gerner EW and Garewal H: Reactive nitrogen species in colon carcinogenesis. Antioxid. Redox. Signal 1: 449-467, 1999.
10. Wu T: Cyclooxygenase-2 in hepatocellular carcinoma. Cancer Treat Rev 32: 28-44, 2006.
11. Connelly ST, Macabeo-Ong M, Dekker N, Jordan RC and Schmidt BL: Increased nitric oxide levels and iNOS overexpression in oral squamous cell carcinoma. Oral Oncol 41: 261-267, 2005.
12. Pannone G, Bufo P, Caiaffa MF, Serpico R, Lanza A, Lo Muzio L, Rubini C, Staibano S, Petruzzi M, De Benedictis M, Tursi A, De Rosa G and Macchia L: Cyclooxygenase-2 expression in oral squamous cell carcinoma. Int J Immunopathol Pharmacol 17: 273-282, 2004.
13. Yu HP, Xu SQ, Liu L, Shi LY, Cai XK, Lu WH, Lu B, Su YH and Li YY: Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus. Cancer Lett 198: 193-201, 2003.
14. Klaunig JE and Kamendulis LM: The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44: 239-267, 2004.
15. Li C, Shintani S, Terakado N, Klosek S K, Ishikawa T, Nakashiro K and Hamakawa H: Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 34: 559-565, 2005.
16. Li Q, Withoff S and Verma IM: Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol 26: 318-325, 2005.
17. Gloire G, Legrand-Poels S and Piette J: NF-kappaB activation by reactive oxygen species: Fifteen years later. Biochem Pharmacol 72: 1493-1505, 2006.
18. Viatour P, Merville M P, Bours V and Chariot A: Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30: 43-52, 2005.
19. Bindhu OS, Ramadas K, Sebastian P and Pillai MR: High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck 28: 916-925, 2006.
20. Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ and Yarbrough WG: Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-(kappa)B Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma. Cancer Res 66: 8210-8218, 2006.
21. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amif S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466, 2004.
22. Ma N, Tagawa T, Hiraku Y, Murata M, Ding X and Kawanishi S: 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide 14: 137-143, 2006.
23. Karp JM, Rodrigo KA, Pei P, Pavlick MD, Andersen JD, McTigue DJ, Fields HW and Mallery SR: Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues. Toxicol Lett 158: 50-60, 2005.
24. Rinaldi AL, Morse MA, Fields HW, Rothas DA, Pei P, Rodrigo KA, Renner RJ and Mallery SR: Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa. Cancer Res 62: 5451-5456, 2002.
25. Rodrigo KA, Rawal Y, Renner RJ, Schwartz SJ, Tian Q, Larsen PE and Mallery SR: Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr Cancer 54: 58-68, 2006.
26. Woo CH, Eom YM, Yoo MH, You HJ, Han HJ, Song WK, Yoo YJ, Chun JS and Kin JH: Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 275: 32357-32362, 2000.
27. Guoquing C: Goeddel. TNF-R1 Signaling: a beautiful pathway. Science 296: 1643-1635, 2002.
28. Shen H-N and Pervaiz S: TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20: 1589-1598, 2006.
29. Mallery SR, Clark YM, Ness GM, Minshawi O, Pei P and Hohl CM: Thiol Redox Modulation of Doxorubicin Mediated Cytotoxicity in Cultured AIDS-Related Kaposi's Sarcoma Cells. J Cell Biochem 73: 259-277, 1999.
30. Bancroft CC, Chen Z, Dong G, Sunwoo J B, Yeh N, Park C and Van WC: Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin Cancer Res 7: 435-442, 2001.
31. Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K and Ueda Y: Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma. Anticancer Res 22: 1039-1044, 2002.
32. Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A and Wennerberg J: Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 83: 775-781, 2000.
33. Brat DJ, Bellail AC and Van Meir EG: The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-oncol 7: 122-133, 2005.
34. Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, Yeh NT, Mukaida N and Van Waes C: IL-1Alpha promotes nuclear factor-kappaB and AP-1 induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 7: 1812-1820, 2001.
35. Ergun S, Kilic N, Fiedler W and Mukhopadhyay AK: Vascular endothelial growth factor and its receptors in normal human testicular tissue. Mol Cell Endocrinol 131: 9-20, 1997.
36. Cabiscol E and Ros J: Oxidative damage to proteins: structural modifications and consequences in cell function. In: Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases. Dalle-Donne I, Scaloni A, Butterfield DA (eds.). New York, Wiley Interscience, pp. 399-471, 2006.
37. Reeves EP, Lu H, Jacobs HL, Messina CGM, Bolsover S, Gabella G, Potma EO, Warley A, Roes J and Segal A: Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416: 291-297, 2002.
38. Ahn KS, Sethi G and Aggarwal BB: Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-κB (NF-κB) signaling pathway leading to suppression of NF-κB regulated antiapoptotic and metastatic gene products. Mol Pharmacol 71: 209-219, 2007.
39. Halliwell B: Oxidative stress in cell culture: an underappreciated problem? FEBS Letts 540: 3-6, 2003.
40. Smith AR, Visioli F and Hagen TM: Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB J 16: 1102-1104, 2002.
41. Bancroft CC, Chen Z, Yeh J, Sunwoo J B, Yeh NT, Jackson S, Jackson C and Van WC: Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 99: 538-548, 2002.
42. Ulanovski D, Stern Y, Roizman P, Shpitzer T, Popovtzer A and Feinmesser R: Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue. Oral Oncol 40: 532-537, 2004.
43. Squarize CH, Castilho RM, Sriurangpong V, Pinto DC and Gutkind JS: Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia 8: 733-746, 2006.
44. Valko M, Rhodes CJ, Moncol J, Izakovic M and Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40, 2006.
45. Liss C, Fekete M J, Hasina R, Lam CD and Lingen MW: Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 93: 781-785, 2001.
46. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC and Roy S: Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem 277: 33284-33290, 2002.
47. Weydert CJ, Waugh TA, Ritchie JM, Iyer K S, Smith JL, Li L, Spitz DR and Oberley LW: Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med 41: 226-237, 2006.
48. Hayden MS and Ghosh S: Signaling to NF-kappaB. Gene Devel 18: 2195-2224, 2004.
49. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM and Aggarwal BB: Evidence that TNF-TNF ALPHAR1-TRADD-TRAF2-RIP- TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 26: 1385-1397, 2006.
50. Hattori Y, Kasai K and Gross SS: NO suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovasc Res 63: 31-40, 2004.
51. Hu TM, Hayton WL, Morse MA and Mallery SR: Dynamic and biphasic modulation of nitrosation reaction by superoxide dismutases. Biochem. Biophys Res Commun 295: 1125-1134, 2002.
52. Li J, Ireland GW, Farthing PM and Thornhill MH: Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 106: 661-666, 1996.
53. Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G and Giavazzi R: Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63: 5224-5229, 2003.
54. Pei P, Horan MP, Hille R, Hemann CF, Schwendeman SP and Mallery SR: Reduced nonprotein thiols inhibit activation and function of MMP-9. Implications for Chemoprevention. Free Rad Biol Med 41: 1315-1324, 2006.
55. Nakayama H, Ikebe T, Beppu M and Shirasuna K: High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer 92: 3037-3044, 2001.